Results 71 to 80 of about 4,708 (131)

Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis. [PDF]

BMC Gastroenterol, 2023
Liu Z, Zhao Z, Ma X, Liu S, Xin Y.
europepmc   +1 more source

Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]

Neurol Neuroimmunol Neuroinflamm
Torkildsen Ø, Bru ANS, Behzadi GIN, Myhr KM.   +3 more
europepmc   +1 more source

Cost–effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece

Journal of Comparative Effectiveness Research
Aim: This study assessed the clinical impact and cost–effectiveness of switching from tenofovir disoproxil fumarate (TDF) to either tenofovir alafenamide (TAF) or entecavir (ETV) in a Greek chronic hepatitis B (CHB) population.
Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, Sushanth Jeyakumar, Nathaniel J Smith, Alon Yehoshua, Evangelos Cholongitas   +6 more
doaj   +1 more source

Tenofovir alafenamide fumarate use for HIV pre-exposure prophylaxis and weight gain. [PDF]

Sci Rep
Shi F, Xia H, Weissman S, Li X, Yang X.
europepmc   +1 more source

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial. [PDF]

J Viral Hepat
Luo Q, Xu W, Zhang Y, Li X, Lai J, Li J, Zheng X, Deng H, Chen L, Zhu X, Xie C, Peng L.   +11 more
europepmc   +1 more source

Pharmacokinetics and efficacy of topical inserts containing tenofovir alafenamide fumarate and elvitegravir administered rectally in macaques. [PDF]

EBioMedicine, 2022
Makarova N, Singletary T, Peet MM, Mitchell J, Holder A, Dinh C, Agrahari V, Mendoza M, Pan Y, Heneine W, Clark MR, García-Lerma JG, Smith JM, Doncel GF.   +13 more
europepmc   +1 more source

Efficacy and tolerability of tenofovir alafenamide fumarate prophylaxis in HBV-infected individuals receiving chemo/immunosuppressive therapy. [PDF]

Hepatol Forum
Dilber F, Durak S, Unsal Y, Demir M, Yildirim AE, Ellik ZM, Mehdiyev S, Adanir H, Yapali S, Demirtas CO, Ucbilek E, Balaban Y, Ekmen N, Gokcan H, Koc ES, Dincer D, Sezgin O, Simsek H, Tozun N, Arslan M, Idilman R, Etik DO, Gokcen P, Ari D, Ozdil K, Akdogan M, Boyacioglu S.   +26 more
europepmc   +1 more source

Effect of alcohol exposure on the efficacy and safety of tenofovir alafenamide fumarate, a major medicine against human immunodeficiency virus. [PDF]

Biochem Pharmacol, 2022
Liu W, Yu S, Yan B.
europepmc   +1 more source

Efficacy and Safety of Tenofovir Alafenamide Fumarate and Tenofovir Disoproxil Fumarate for Preventing Mother-to-Child Transmission of Hepatitis B in Treatment-Naïve mothers: An Observational Study. [PDF]

Virol J
Yang X, Chen J, Duan L, Li X, Cheng W, Chen Y, Huang Y, Huang Z.   +7 more
europepmc   +1 more source

Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in China. [PDF]

Lancet Reg Health West Pac
Wu X, Ma P, Ruan L, Chen Y, Wang R, Song Y, Cai Y, Chen F, Zhang L, Fitzpatrick T, Li B, Wu G, Meng X, Fan S, Qiao Y, Gao Y, Hong Z, Zhang T, Zou M, Wang L, Fu Y, Su B, Zou J, Wang H, Zou H.   +24 more
europepmc   +1 more source